Cargando…
Use of Continuous Intravenous Anakinra Infusion in Multisystem Inflammatory Syndrome in Children
Coronavirus disease (COVID-19) is an emergency pandemic with a high mortality rate worldwide. One of its complications in children is developing multisystemic inflammatory syndrome related to cytokine storm. Anakinra is a recombinant human interleukin-1 (IL-1) receptor antagonist used to suppress th...
Autores principales: | Alolayan, Abdulaziz, Aldamegh, Abdullah S., Alkhayrat, Azzah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9991479/ https://www.ncbi.nlm.nih.gov/pubmed/36895203 http://dx.doi.org/10.1155/2023/8530060 |
Ejemplares similares
-
Anakinra in Refractory Multisystem Inflammatory Syndrome in Children (MIS-C)
por: Bhat, Chandrika S., et al.
Publicado: (2021) -
Multisystem Inflammatory Syndrome in an Adult (MIS-A) Successfully Treated with Anakinra and Glucocorticoids
por: Cattaneo, Paolo, et al.
Publicado: (2021) -
Efficacy of anakinra on rebound of multisystem inflammatory syndrome
por: Brisca, Giacomo, et al.
Publicado: (2022) -
Continuous Intravenous Anakinra Infusion to Calm the Cytokine Storm in Macrophage Activation Syndrome
por: Monteagudo, Luke Adam, et al.
Publicado: (2020) -
Continuous IV infusion of anakinra
por: Saunders, Brittney N., et al.
Publicado: (2023)